中东和非洲透明质酸市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

中东和非洲透明质酸市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Published Report
  • Jan 2023
  • MEA
  • 350 页面
  • 桌子數: 300
  • 图号: 39

Middle East And Africa Hyaluronic Acid Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 263.81 Million
Diagram Market Size (Forecast Year)
USD 409.69 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>中东和非洲透明质酸市场 - 按等级(化妆品级和医药级)、类型(水解透明质酸、乙酰化透明质酸钠和透明质酸钠)、应用(美学、骨关节炎、药物 API、化妆品、眼科和其他)、最终用户(医疗水疗和美容中心、皮肤病诊所和整容手术中心)、分销渠道(直接招标和零售销售)行业趋势和预测到 2030 年。

透明质酸市场

中东和非洲透明质酸市场分析与洞察

透明质酸主要用于美容和护肤产品。它可快速恢复伤口,减少面部细纹、皱纹和皮肤老化,并治愈割伤和烧伤等。它含有维生素 C,可提亮肤色。含有透明质酸的美容产品(例如保湿霜、面霜、爽肤水和精华液)可为皮肤提供营养。

透明质酸市场

透明质酸市场

Data Bridge Market Research 分析称,在 2023 年至 2030 年的预测期内,中东和非洲透明质酸市场以 5.7% 的复合年增长率增长,预计到 2030 年将从 2022 年的 2.6381 亿美元增至 4.0969 亿美元。

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2020-2016)

定量单位

收入(百万美元)

涵盖的领域

按等级(化妆品级和药品级)、类型(水解透明质酸、乙酰化透明质酸钠和透明质酸钠)、应用(美学、骨关节炎、药品 API、化妆品、眼科等)、最终用户(医疗水疗和美容中心、皮肤病诊所和整形外科中心)、分销渠道(直接招标和零售)。

覆盖国家

南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区。

涵盖的市场参与者

Fidia Farmaceutici SpA、AbbVie.、华熙生物科技股份有限公司、GALDERMA、LG Chem、Anika Therapeutics, Inc.、Abbott、VIRCHOW BIOTECH、Kewpie Corporation、Merz North America, Inc.、LABORATOIRES FILLMED、Prollenium Medical Technologies.、Huons、Contipro as、Lifecore Biomedical, Inc.、BioScience GmbH、Teoxane、Bioxis Pharmaceuticals、山东拓普生物科技有限公司、Bohus BioTech AB、RIVER PHARMA srl、Symatese、Stanford Chemicals owned by Oceania International LLC、Bioiberica SAU、GENESIS pharmacy services 和 Brickell Men's Products 等

市场定义

透明质酸 (HA) 也被称为透明质酸,是一种阴离子、非硫酸化的氨基葡聚糖,广泛分布于结缔、上皮和神经组织中。透明质酸是关节软骨的重要组成部分,像一层外衣(软骨细胞)一样包裹着软骨中的每个细胞。软骨的坚固性是由于这些聚集体吸收了水(其抗压性)。软骨中透明质酸的分子量(大小)会随着年龄的增长而减小,但数量会增加。人体自然含有 HA。关节和眼睛中含有最多的 HA。这种化学物质能够保持皮肤的光滑、湿润。因此,许多整形外科医生将其用作注射剂来延缓皮肤衰老的迹象。

微创手术的日益普及以及全球对医药和化妆品中透明质酸的认识和需求不断增长是预测期内市场增长的主要驱动因素。研究质量的大幅提高以及研究机会的增加得益于市场参与者采取的各种战略举措。多年来,他们采取了产品发布、合作、合并、收购等举措,预计将引领并创造更多市场机会。

中东和非洲透明质酸市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容:

司机

  • 提高对美容注射剂或真皮填充剂的认识

基于透明质酸的真皮填充剂是一种侵入性较小的美容方法。皮肤病问题在全球很常见。了解治疗皮肤相关问题和恢复皮肤皱纹的产品已成为主要关注点。已经启动了各种计划来提高人们对正确使用透明质酸注射剂的认识。

意识的增强将使消费者能够选择正确的痤疮和皱纹治疗方法,并根据正确的原因选择正确的产品(肉毒杆菌注射、真皮填充剂)。这将导致销售额上升、产品组合增加和产品线扩大。这一因素有望推动市场增长。

  • 使用侵入性透明质酸类皮肤填充剂

基于透明质酸的真皮填充剂是一种侵入性较小的美容方法,在全球范围内正迅速增加。这些是用于面部修复、面部体积恢复和美学改善的流行美容程序。

它们用途广泛,可用于治疗细纹和皱纹。此外,它们还用于治疗痤疮、皱纹和疤痕以及丰唇、丰颊和丰下巴。老年人口的增加提高了非侵入性手术方案的必要性。

使用透明质酸基真皮填充剂将减少选择常规手术的机会。治疗成本最低,这一因素将促进市场增长。

限制

  • 未经授权或替代性皮肤填充剂的供应阻碍了市场

随着透明质酸类真皮填充剂的美容应用的广泛普及,预计这些产品的若干限制因素将在未来几年阻碍中东和非洲市场的增长。

由于其高有效率、患者满意度以及在动态皱纹方面的使用率,肉毒杆菌毒素类填充剂正在全球引领非手术美容手术。

此外,其他可生物降解的填充剂,如羟基磷灰石钙 (CaHA) 和聚-L-乳酸,作为高寿命植入物的替代填充剂越来越受欢迎。

据观察,医生们不愿意使用低成本的非法产品,因为这样做存在风险。相反,真皮填充剂领域存在的非法产品将加剧价格竞争,尤其是在透明质酸领域。提供高单价的大型公司有能力通过提供多种产品组合并在不同产品部门销售产品来竞争。

为了弥补透明质酸真皮填充剂价格较低的缺陷,颗粒和聚合物制造商必须大力推广产品。该细分市场的产品各不相同。制造商将更多地关注真皮填充剂所用材料的强度,而不是成本价格。

机会

  • 透明质酸产品的新技术和发展

先进的创新技术改善了皮肤和其他身体部位的美容治疗,护肤品行业是变化最快的行业之一。本土品牌的活性成分、成分型护肤品和美容领域正在见证投资的增加,消费者也积极参与其中。先进的创新技术和透明质酸产品的发展推动了市场对透明质酸的需求。

透明质酸真皮产品以透明质酸为基础,可矫正面部瑕疵、补充体积并突出面部某些部位。真皮产品的进步为增强、恢复和定义面部特征提供了一种有效的方法。透明质酸基产品和真皮填充剂程序的进步吸引了消费者对化妆品的兴趣。因此,这意味着透明质酸真皮产品的技术进步有望成为市场增长的机会。

挑战

  • 产品召回不断升级

透明质酸类产品的召回极大地影响了市场增长。监管机构因健康和安全问题召回美容和化妆品。每个国家都有自己的监管机构,负责监督与医疗保健相关的产品的监管。

出于对患者健康安全问题的考虑,例如内容不准确或成分错误,公司或监管机构召回产品是影响市场增长的一些主要问题,因为患者的安全和健康是任何市场在市场上推出产品的最重要标准。

最新动态

  • 2022年2月,艾尔建(AbbVie Inc. 的子公司)宣布 FDA 批准 JUVÉDERM VOLBELLA XC 用于改善21岁以上成年人的眶下凹陷。此举有助于该公司扩大其在美国市场的美容产品组合。
  • 2021年2月,总部位于捷克共和国的知名透明质酸制造商Contipro宣布推出其名为HyRetin的新型抗衰老和抗痤疮治疗产品,该产品可提高皮肤的可见度。

中东和非洲透明质酸市场范围

中东和非洲的透明质酸市场根据等级、类型、应用、最终用户和分销渠道分为五个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,以便做出战略决策,确定核心市场应用。

年级

  • 化妆品级
  • 医药级

根据等级,市场分为化妆品级和药品级。

类型

  • 水解透明质酸
  • 乙酰化透明质酸钠
  • 透明质酸钠

根据类型,市场分为水解透明质酸、乙酰化透明质酸钠和透明质酸钠。

应用

  • 美学
  • 骨关节炎
  • 制药原料药
  • 化妆品
  • 眼科
  • 其他的

根据应用,市场细分为美学、骨关节炎、药物 API、化妆品、眼科等。

最终用户

  • 制药行业
  • 皮肤科诊所
  • 整形外科中心
  • 其他的

根据最终用户,市场分为制药行业、皮肤病诊所、整形外科中心和其他行业。

分销渠道

  • 直接招标
  • 零售销售

根据分销渠道,市场分为直接招标和零售。

中东和非洲透明质酸市场区域分析/见解   

对中东和非洲透明质酸市场进行了分析,并按国家、等级、类型、应用、最终用户和分销渠道提供了市场规模洞察和趋势。

本市场报告涵盖的国家包括南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲的其他国家。

  • 2023 年,南非在市场份额和收入方面占据中东和非洲透明质酸市场的主导地位,并将在预测期内继续保持其主导地位。这是由于产品批准数量的增加。

报告的国家部分还提供了影响单个市场因素和市场法规变化的信息,这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了中东和非洲品牌的存在和可用性以及它们因本土和国内品牌的竞争而面临的挑战以及销售渠道的影响。

竞争格局和中东和非洲透明质酸市场份额分析

中东和非洲透明质酸市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、中东和非洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

中东和非洲透明质酸市场的一些主要参与者包括 Fidia Farmaceutici SpA、AbbVie.、Bloomage Biotechnology Co., Ltd.、GALDERMA、LG Chem、Anika Therapeutics, Inc.、Abbott、VIRCHOW BIOTECH、Kewpie Corporation、Merz North America, Inc.、LABORATOIRES FILLMED、Prollenium Medical Technologies.、Huons、Contipro as、Lifecore Biomedical, Inc.、BioScience GmbH、Teoxane、Bioxis Pharmaceuticals、SHANDONG TOPSCIENCE BIOTECH CO., LTD.、Bohus BioTech AB、RIVER PHARMA srl、Symatese、Stanford Chemicals owned by Oceania International LLC、Bioiberica SAU、GENESIS pharmacy services 和 Brickell Men's Products 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 GRADE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES

4.4 INDUSTRY INSIGHTS

5 REGULATORY FRAMEWORK

5.1 EGULATORY SCENARIO IN THE U.S.

5.2 REGULATORY SCENARIO IN EUROPE

5.3 REGULATORY SCENARIO IN CHINA

5.4 REGULATORY SCENARIO IN AUSTRALIA

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS

6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS

6.1.3 RISE IN PRODUCT APPROVALS

6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES

6.2 RESTRAINTS

6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET

6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES

6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION

6.3 OPPORTUNITIES

6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS

6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS

6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.4 INCREASING RESEARCH AND DEVELOPMENT

6.4 CHALLENGES

6.4.1 ESCALATING PRODUCT RECALL

6.4.2 LACK OF EXPERTISE

7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE

7.1 OVERVIEW

7.2 COSMETIC GRADE

7.2.1 GENDER

7.2.1.1 FEMALE PRODUCTS

7.2.1.2 MEN’S PRODUCT

7.2.2 PRODUCT TYPE

7.2.2.1 SKIN CARE

7.2.2.2 MAKEUP

7.2.2.3 CLEANSING

7.2.2.4 HAIR CARE

7.2.2.5 OTHERS

7.2.3 PROCEDURE

7.2.3.1 WRINKLE REMOVAL

7.2.3.2 SKIN SMOOTHENING

7.2.3.3 FACE LIFT

7.2.3.4 LIP AUGMENTATION

7.2.3.5 CHIN AUGMENTATION

7.2.3.6 FAT INJECTION

7.2.3.7 FACE LINE CORRECTION

7.2.3.8 ACNE SCAR TREATMENT

7.2.3.9 LIP PLUM

7.2.3.10 EAR LOBE REJUVENATION

7.2.3.11 LIPOATROPHY TREATMENT

7.2.3.12 OTHERS

7.3 PHARMACEUTICAL GRADE

7.3.1 TYPE

7.3.1.1 MEDICAL GRADE HYALURONIC ACID

7.3.1.2 INJECTION GRADE HYALURONIC ACID

7.3.2 PRODUCT TYPE

7.3.2.1 TOPICAL PREPARATIONS

7.3.2.2 INTRA-ARTICULAR INJECTION

7.3.2.2.1 PREFILLED INJECTIONS

7.3.2.2.2 VIAL

7.3.2.3 EYE DROPS

7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS

7.3.2.5 OTHERS

8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE

8.1 OVERVIEW

8.2 SODIUM HYALURONATE

8.2.1 MOLECULAR WEIGHT

8.2.1.1 HIGH MOLECULAR WEIGHT

8.2.1.2 LOW MOLECULAR WEIGHT

8.2.1.3 MEDIUM MOLECULAR WEIGHT

8.2.2 BY TYPE

8.2.2.1 COSMETIC GRADE

8.2.2.1.1 GENDER

8.2.2.1.1.1 FEMALE PRODUCTS

8.2.2.1.1.2 MEN'S PRODUCT

8.2.2.1.2 PRODUCT TYPE

8.2.2.1.2.1 SKIN CARE

8.2.2.1.2.2 MAKEUP

8.2.2.1.2.3 CLEANSING

8.2.2.1.2.4 HAIR CARE

8.2.2.1.2.5 OTHERS

8.2.2.2 PHARMACEUTICAL GRADE

8.2.2.2.1 TYPE

8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.2.2.2.2 PRODUCT TYPE

8.2.2.2.2.1 TOPICAL PREPARATIONS

8.2.2.2.2.2 INTRA-ARTICULAR INJECTION

8.2.2.2.2.2.1 PREFILLED INJECTIONS

8.2.2.2.2.2.2 VIAL

8.2.2.2.2.3 EYE DROPS

8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.2.2.2.2.5 OTHERS

8.3 HYDROLYZED HYALURONIC ACID

8.3.1 MOLECULAR WEIGHT

8.3.1.1 HIGH MOLECULAR WEIGHT

8.3.1.2 LOW MOLECULAR WEIGHT

8.3.1.3 MEDIUM MOLECULAR WEIGHT

8.3.2 BY TYPE

8.3.2.1 COSMETIC GRADE

8.3.2.1.1 GENDER

8.3.2.1.1.1 FEMALE PRODUCTS

8.3.2.1.1.2 MEN'S PRODUCT

8.3.2.1.2 PRODUCT TYPE

8.3.2.1.2.1 SKIN CARE

8.3.2.1.2.2 MAKEUP

8.3.2.1.2.3 CLEANSING

8.3.2.1.2.4 HAIR CARE

8.3.2.1.2.5 OTHERS

8.3.2.2 PHARMACEUTICAL GRADE

8.3.2.2.1 TYPE

8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.3.2.2.2 PRODUCT TYPE

8.3.2.2.2.1 TOPICAL PREPARATIONS

8.3.2.2.2.2 INTRA-ARTICULAR INJECTION

8.3.2.2.2.2.1 PREFILLED INJECTIONS

8.3.2.2.2.2.2 VIAL

8.3.2.2.2.3 EYE DROPS

8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.3.2.2.2.5 OTHERS

8.4 SODIUM ACETYLATED HYALURONIC ACID

8.4.1 MOLECULAR WEIGHT

8.4.1.1 HIGH MOLECULAR WEIGHT

8.4.1.2 LOW MOLECULAR WEIGHT

8.4.1.3 MEDIUM MOLECULAR WEIGHT

8.4.2 BY TYPE

8.4.2.1 COSMETIC GRADE

8.4.2.1.1 GENDER

8.4.2.1.1.1 FEMALE PRODUCTS

8.4.2.1.1.2 MEN'S PRODUCT

8.4.2.1.2 PRODUCT TYPE

8.4.2.1.2.1 SKIN CARE

8.4.2.1.2.2 MAKEUP

8.4.2.1.2.3 CLEANSING

8.4.2.1.2.4 HAIR CARE

8.4.2.1.2.5 OTHERS

8.4.2.2 PHARMACEUTICAL GRADE

8.4.2.2.1 TYPE

8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.4.2.2.2 PRODUCT TYPE

8.4.2.2.2.1 TOPICAL PREPARATIONS

8.4.2.2.2.2 INTRA-ARTICULAR INJECTION

8.4.2.2.2.2.1 PREFILLED INJECTIONS

8.4.2.2.2.2.2 VIAL

8.4.2.2.2.3 EYE DROPS

8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.4.2.2.2.5 OTHERS

9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 AESTHETICS

9.3 OSTEOARTHRITIS

9.4 COSMETICS

9.5 OPHTHALMOLOGY

9.6 PHARMACEUTICAL API

9.7 OTHERS

10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER

10.1 OVERVIEW

10.2 DERMATOLOGY CLINICS

10.3 COSMETIC SURGERY CENTERS

10.4 MEDICAL SPAS AND BEAUTY CENTERS

10.5 OTHERS

11 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL PHARMACY

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY REGION

12.1 MIDDLE EAST AND AFRICA

12.1.1 SOUTH AFRICA

12.1.2 SAUDI ARABIA

12.1.3 U.A.E.

12.1.4 EGYPT

12.1.5 ISRAEL

12.1.6 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 FIDIA FARMACEUTICI S.P.A. (2022)

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 ABBVIE INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 GALDERMA

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 LG CHEM (2022)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ABBOTT (2022)

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ANIKA THERAPEUTICS, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 COMPANY SHARE ANALYSIS

15.7.4 PRODUCT PORTFOLIO

15.7.5 RECENT DEVELOPMENTS

15.8 BIOSCIENCE GMBH

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 BIOXIS PHARMACEUTICALS

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 BIOIBERICA S.A.U

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 BOHUS BIOTECH AB

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BRICKELL MEN'S PRODUCTS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CONTIPRO A.S.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 FILLMED

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 GENESIS

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 HUONS

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 KEWPIE CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 LIFECORE BIOMEDICAL, INC.(2022)

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 PROLLENIUM MEDICAL TECHNOLOGIES

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 RIVER PHARMA S.R.L.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENTS

15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENTS

15.24 SYMATESE

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 TEOXANE

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 VIRCHOW BIOTECH

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

表格列表

TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:

TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME

TABLE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 58 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 59 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 62 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 63 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 65 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 66 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 67 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 68 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 69 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 70 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 71 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 73 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 74 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 78 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 79 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 82 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 85 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 86 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 88 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 89 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 91 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 92 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 93 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 94 MIDDLE EAST AND AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 95 SOUTH AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 96 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 97 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 99 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 100 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 101 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 102 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 103 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 104 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 106 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 107 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 109 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 110 SOUTH AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 111 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 112 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 114 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 116 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 119 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 120 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 121 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 125 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 126 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 127 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 128 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 129 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 130 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 SOUTH AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 133 SOUTH AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 134 SOUTH AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 135 SOUTH AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 136 SAUDI ARABIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 137 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 138 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 140 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 141 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 142 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 144 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 145 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 147 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 148 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 150 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 151 SAUDI ARABIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 152 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 153 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 154 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 155 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 156 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 157 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 158 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 159 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 160 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 162 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 163 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 165 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 166 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 167 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 168 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 169 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 170 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 171 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 172 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 173 SAUDI ARABIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 SAUDI ARABIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 175 SAUDI ARABIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 176 SAUDI ARABIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 177 U.A.E. HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 178 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 179 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 180 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 181 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 182 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 183 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 184 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 185 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 186 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 187 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 188 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 189 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 191 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 192 U.A.E. HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 194 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 195 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 196 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 198 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 200 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 201 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 202 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 203 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 205 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 U.A.E. INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 208 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 210 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 212 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 213 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 U.A.E. HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 215 U.A.E. HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 216 U.A.E. HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 217 U.A.E. RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 218 EGYPT HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 219 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 220 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 221 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 222 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 223 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 224 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 225 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 226 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 227 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 228 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 229 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 230 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 231 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 232 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 233 EGYPT HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 234 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 235 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 236 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 237 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 238 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 239 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 240 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 241 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 242 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 243 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 244 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 245 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 246 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 247 EGYPT INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 248 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 249 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 250 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 251 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 253 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 254 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 255 EGYPT HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 256 EGYPT HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 257 EGYPT HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 258 EGYPT RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 259 ISRAEL HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 260 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 261 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 263 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 264 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 265 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 266 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 267 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 268 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 269 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 270 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 271 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 272 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 273 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 274 ISRAEL HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 275 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 276 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 277 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 278 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 279 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 280 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 282 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 283 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 284 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 285 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 286 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 288 ISRAEL INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 289 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 290 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 291 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 292 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 293 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 294 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 295 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 296 ISRAEL HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 ISRAEL HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 298 ISRAEL HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 299 ISRAEL RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 300 REST OF MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DBMR POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: END USER COVERAGE GRID

FIGURE 10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA HYALURONIC ACID MARKET

FIGURE 14 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2022

FIGURE 15 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)

FIGURE 17 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2022

FIGURE 19 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 21 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2022

FIGURE 23 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2022

FIGURE 27 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: SNAPSHOT (2022)

FIGURE 35 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022)

FIGURE 36 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: GRADE (2023-2030)

FIGURE 39 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Middle East and Africa Hyaluronic Acid Market is projected to grow at a CAGR of 5.7% during the forecast period by 2030.
The future market value of the Middle East and Africa Hyaluronic Acid Market is expected to reach USD 409.69 million by 2030.
The major players in the Middle East and Africa Hyaluronic Acid Market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., etc.
The countries covered in the Middle East and Africa Hyaluronic Acid Market are South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.